UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$188M |
| 2 |
Yelp
YELP
|
+$182M |
| 3 |
General Motors
GM
|
+$141M |
| 4 |
American Express
AXP
|
+$138M |
| 5 |
Comcast
CMCSA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$331M |
| 2 |
Crown Castle
CCI
|
+$303M |
| 3 |
Cardinal Health
CAH
|
+$204M |
| 4 |
Gilead Sciences
GILD
|
+$157M |
| 5 |
Apple
AAPL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.6% |
| 2 | Healthcare | 13.9% |
| 3 | Technology | 13.4% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRE
951
DELISTED
Veris Residential
VRE
| $5.32M | 0.01% |
247,541
+14,076
| +6% | +$295K |
|
952
Tenet Healthcare
THC
$21.1B
| $5.32M | 0.01% |
126,183
+9,001
| +8% | +$392K |
|
|
FRAN
953
DELISTED
Francesca's Holdings Corporation
FRAN
| $5.23M | 0.01% |
23,687
-952
| -4% | -$208K |
|
954
Nordson
NDSN
$17.3B
| $5.22M | 0.01% |
70,255
-2,961
| -4% | -$216K |
|
|
BEL
955
DELISTED
Belmond Ltd.
BEL
| $5.22M | 0.01% |
345,397
+133,000
| +63% | +$1.9M |
|
|
WRI
956
DELISTED
Weingarten Realty Investors
WRI
| $5.18M | 0.01% |
188,891
+1,900
| +1% | +$56.1K |
|
|
ZU
957
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
| $5.18M | 0.01% |
+125,000
| New | +$4.79M |
|
|
BEE
958
DELISTED
STRATEGIC HOTELS & RESORTS, INC
BEE
| $5.17M | 0.01% |
546,900
+71,700
| +15% | +$634K |
|
|
PKT
959
DELISTED
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
| $5.17M | 0.01% |
343,968
-19,396
| -5% | -$281K |
|
|
NFX
960
DELISTED
Newfield Exploration
NFX
| $5.14M | 0.01% |
208,688
+16,992
| +9% | +$477K |
|
961
Revvity
RVTY
$12.8B
| $5.13M | 0.01% |
124,446
+10,200
| +9% | +$390K |
|
962
ATI
ATI
$28B
| $5.06M | 0.01% |
142,047
+1,000
| +0.7% | +$32.9K |
|
|
BLUE
963
DELISTED
bluebird bio
BLUE
| $5.05M | 0.01% |
18,589
-354
| -2% | -$98.9K |
|
964
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $5.04M | 0.01% |
120,802
+130
| +0.1% | +$5.27K |
|
|
NDZ
965
DELISTED
NORDION INC COM STK (CDA)
NDZ
| $5.03M | 0.01% |
592,965
+468,568
| +377% | +$3.94M |
|
|
LUMO
966
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $5.03M | 0.01% |
+25,394
| New | +$4.52M |
|
967
MacroGenics
MGNX
$248M
| $5M | 0.01% |
+182,121
| New | +$4.76M |
|
968
Omega Healthcare
OHI
$14.8B
| $4.94M | 0.01% |
165,774
-15,151
| -8% | -$480K |
|
969
Compañía de Minas Buenaventura
BVN
$8.38B
| $4.94M | 0.01% |
440,052
+46,016
| +12% | +$570K |
|
|
QCOR
970
DELISTED
QUESTCOR PHARMA INC
QCOR
| $4.92M | 0.01% |
90,274
-111,537
| -55% | -$6.59M |
|
971
Pacira BioSciences
PCRX
$991M
| $4.9M | 0.01% |
85,299
-86,900
| -50% | -$4.57M |
|
972
Cadence Design Systems
CDNS
$92.8B
| $4.87M | 0.01% |
347,451
-140,104
| -29% | -$1.88M |
|
|
TPH
973
DELISTED
Tri Pointe Homes
TPH
| $4.81M | 0.01% |
241,200
-12,500
| -5% | -$214K |
|
|
SRGA
974
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $4.78M | 0.01% |
45,041
+5,621
| +14% | +$545K |
|
975
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.81B
| – | – |
0
| – | – |
|
Similar funds
UBS AM's Q4 2013 Portfolio in Review
As of Q4 2013, UBS AM held 2,637 positions worth $87.5B, up 8.1% from $80.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2013 filing shows 130 new, 1,010 increased, 1,128 reduced and 103 closed positions. Its largest new stake was Trip.com Group: 2,309,000 shares worth $57.3M. The largest sale was eBay, an estimated $331M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
- UBS AM's largest Q4 2013 buy was Trip.com Group: 2,309,000 shares worth $57.3M.
- UBS AM added most to Regeneron Pharmaceuticals in Q4 2013, an estimated $188M increase.
- UBS AM's biggest Q4 2013 reduction was eBay, cutting an estimated $331M.
- UBS AM fully exited DELL INC in Q4 2013, selling an estimated $62.9M.
- UBS AM's ten largest holdings make up 14% of its $87.5B portfolio in Q4 2013.
- UBS AM opened 130 new positions and closed 103 in Q4 2013.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $87.5B.
Based on UBS AM's 13F filing for Q4 2013, filed 31 Jan 2014.